Dongkook Pharmaceutical Co., Ltd. is a Korea-based company engaged in the development, manufacture, and distribution of pharmaceuticals, with a strong focus on Active Pharmaceutical Ingredients (APIs). Since its establishment in 1968, Dongkook has prioritised research and development, alongside technological innovation. The company is renowned for its over-the-counter (OTC) products with high brand values in Korea and has developed an extensive range of therapeutic products, including anesthetics, contrast media, and anti-cancer agents. Dongkook has received recognition from both domestic and foreign authorities for the quality of its finished products, medical devices, and APIs.

Services include:
– Anatomical Therapeutic Chemical (ATC) Classification
– Active Pharmaceutical Ingredients (APIs)
– Development of remedies for oral troubles
– Solutions for skin troubles
– Treatments for gynecological diseases
– Production of contrast media
– Manufacture of medical devices

Through its commitment to quality and innovation, Dongkook Pharmaceutical Co., Ltd. remains a key supplier in the pharmaceutical industry. For more information, visit dkpharm.co.kr.